These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38621963)

  • 1. [Mechanism of traditional Chinese medicine in regulating NLRP3 inflammasomes to alleviate renal interstitial fibrosis in diabetic nephropathy: a review].
    Qiao L; Jin Y; Guo ZA
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1164-1171. PubMed ID: 38621963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy.
    Zhao W; Zhou L; Novák P; Shi X; Lin CB; Zhu X; Yin K
    J Diabetes Res; 2022; 2022():2193768. PubMed ID: 35719709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation.
    Wang S; Li Y; Fan J; Zhang X; Luan J; Bian Q; Ding T; Wang Y; Wang Z; Song P; Cui D; Mei X; Ju D
    Cell Death Dis; 2017 Jul; 8(7):e2937. PubMed ID: 28726774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
    Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
    Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the NLRP3 Inflammasome in Diabetic Nephropathy.
    Yang M; Wang X; Han Y; Li C; Wei L; Yang J; Chen W; Zhu X; Sun L
    Curr Med Chem; 2021; 28(42):8810-8824. PubMed ID: 34225600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complanatoside A targeting NOX4 blocks renal fibrosis in diabetic mice by suppressing NLRP3 inflammasome activation and autophagy.
    Ren C; Bao X; Lu X; Du W; Wang X; Wei J; Li L; Li X; Lin X; Zhang Q; Ma B
    Phytomedicine; 2022 Sep; 104():154310. PubMed ID: 35843189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
    Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
    Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes.
    Zhang L; Jing M; Liu Q
    Life Sci; 2021 Aug; 278():119542. PubMed ID: 33915128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of NLRP3 inflammasome in diabetic neuropathy and prevention and treatment with traditional Chinese medicine].
    Feng HY; Ding R; Zhou Q; Wu TC; Li H; Ma XT; Yue RS
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):300-310. PubMed ID: 36725219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy.
    Wen L; Yang H; Ma L; Fu P
    Mol Cell Biochem; 2021 Mar; 476(3):1377-1386. PubMed ID: 33389490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Selective NLRP3-Inflammasome Inhibitor CY-09 Ameliorates Kidney Injury in Diabetic Nephropathy by Inhibiting NLRP3- inflammasome Activation.
    Yang M; Zhao L
    Curr Med Chem; 2023; 30(28):3261-3270. PubMed ID: 36154582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioscorea zingiberensis ameliorates diabetic nephropathy by inhibiting NLRP3 inflammasome and curbing the expression of p66Shc in high-fat diet/streptozotocin-induced diabetic mice.
    Ren C; Zhou X; Bao X; Zhang J; Tang J; Zhu Z; Zhang N; Bai Y; Xi Y; Zhang Q; Ma B
    J Pharm Pharmacol; 2021 Aug; 73(9):1218-1229. PubMed ID: 34061184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome.
    Ding T; Wang S; Zhang X; Zai W; Fan J; Chen W; Bian Q; Luan J; Shen Y; Zhang Y; Ju D; Mei X
    Phytomedicine; 2018 Mar; 41():45-53. PubMed ID: 29519318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro.
    Li Y; Long W; Zhang H; Zhao M; Gao M; Guo W; Yu L
    Int Immunopharmacol; 2024 Apr; 131():111844. PubMed ID: 38503013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine].
    Wang WW; Han WB; Wan YG; Tu Y; Liu BH; Liu YL; Wu W; Yee HY; Fang QJ; Yao J
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(1):7-13. PubMed ID: 32237405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
    Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
    FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
    Tang ZZ; Zhang YM; Zheng T; Huang TT; Ma TF; Liu YW
    Phytomedicine; 2020 Nov; 78():153314. PubMed ID: 32882582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV ameliorates diabetic nephropathy in
    Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of NLRP3 inflammasome in heart failure and traditional Chinese medicine intervention: a review].
    Wang D; Li FH; Yu X; Gao K; Guo SZ
    Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):894-901. PubMed ID: 38621896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.